Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3062841000168112 | Visipaque (iodixanol 550 mg / 1 mL) injection, 10 x 150 mL bags (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3062851000168114 | Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | Is a | trade product pack | true | Inferred relationship | Some | ||
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | Is a | iodixanol 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | true | Inferred relationship | Some | ||
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | has TPUU | Visipaque 550 mg (iodine 270 mg)/mL injection, 150 mL bag | true | Inferred relationship | Some | 1 | |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | has TP | Visipaque | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | Is a | True | Visipaque 550 mg (iodine 270 mg)/mL injection, 10 x 150 mL bags | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR